Fifty-seven percent of surveyed medtech industry leaders say their organization has realized benefits across functions by implementing or scaling GenAI use cases or “quick wins,” according to a new report from Deloitte.
Product Development Is Leading Use Case For AI Value Creation – Medtech Leaders
Deloitte Center for Health Solutions surveyed 85 leaders from medtech organizations for its report, “Is Generative AI changing the game for medtech?” Respondents replied overwhelmingly “yes,” while acknowledging the industry thus far has only scratched the surface of AI’s potential.
